• 1
    Lusis, A. J., Atherosclerosis. Nature 2000. 407: 233241.
  • 2
    Libby, P., Inflammation in atherosclerosis. Nature 2002. 420: 868874.
  • 3
    Ross, R., Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 1999. 340: 115126.
  • 4
    Dinarello, C. A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009. 27: 519550.
  • 5
    Dinarello, C. A., Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011. 117: 37203732.
  • 6
    Gross, O., Thomas, C. J., Guarda, G.andTschopp, J., The inflammasome: an integrated view. Immunol. Rev. 2011. 243: 136151.
  • 7
    Dinarello, C. A., The interleukin-1 family: 10 years of discovery. FASEB J. 1994. 8: 13141325.
  • 8
    Carruth, L. M., Demczuk, S.and Mizel, S. B., Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J. Biol. Chem. 1991. 266: 1216212167.
  • 9
    Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, al.,Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997. 275: 206209.
  • 10
    Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. and Flavell, R. A., Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995. 267: 20002003.
  • 11
    Keller, M., Ruegg, A., Werner, S.and Beer, H. D., Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008. 132: 818831.
  • 12
    Fettelschoss, A., Kistowska, M., LeibundGut-Landmann, S., Beer, H. D., Johansen, P., Senti, G., Contassot, E. et al., Inflammasome activation and IL-1beta target IL-1alpha for secretion as opposed to surface expression. Proc. Natl. Acad. Sci. USA 2011. 108: 1805518060.
  • 13
    Dinarello, C. A., Biologic basis for interleukin-1 in disease. Blood 1996. 87: 20952147.
  • 14
    Cohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E. et al., Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl. Acad. Sci. USA 2010. 107: 25742579.
  • 15
    Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M. et al., Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol. 2011. 41: 20402051.
  • 16
    Wen, H., Ting, J. P. and O'Neill, L. A., A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation? Nat. Immunol. 2012. 13: 352357.
  • 17
    Chamberlain, J., Francis, S., Brookes, Z., Shaw, G., Graham, D., Alp, N. J., Dower, al., Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS One 2009. 4: e5073.
  • 18
    Chi, H., Messas, E., Levine, R. A., Graves, D. T. and Amar, S., Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 2004. 110: 16781685.
  • 19
    Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M. et al., Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb. Vasc. Biol. 2003. 23: 656660.
  • 20
    Merhi-Soussi, F., Kwak, B. R., Magne, D., Chadjichristos, C., Berti, M., Pelli, G., James, R. W. et al., Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc. Res. 2005. 66: 583593.
  • 21
    Kamari, Y., Werman-Venkert, R., Shaish, A., Werman, A., Harari, A., Gonen, A., Voronov, E. et al.,Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 2007. 195: 3138.
  • 22
    Rader, D. J. and Daugherty, A., Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008. 451: 904913.
  • 23
    Bachmann, M. F. and Dyer, M. R., Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat. Rev. Drug Discov. 2004. 3: 8188.
  • 24
    Spohn, G., Keller, I., Beck, M., Grest, P., Jennings, G. T. and Bachmann, M. F., Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur. J. Immunol. 2008. 38: 877887.
  • 25
    Guler, R., Parihar, S. P., Spohn, G., Johansen, P., Brombacher, F.and Bachmann, M. F., Blocking IL-1alpha but not IL-1beta increases susceptibility to chronic Mycobacterium tuberculosis infection in mice. Vaccine 2011. 29: 13391346.
  • 26
    Patel, S. S., Thiagarajan, R., Willerson, J. T. and Yeh, E. T., Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 1998. 97: 7581.
  • 27
    Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S., Chen, M., Iiyama, M., Davis, V. et al., A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001. 107: 12551262.
  • 28
    Dansky, H. M., Charlton, S. A., Harper, M. M. and Smith, J. D., T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 1997. 94: 46424646.
  • 29
    Galkina, E.and Ley, K., Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007. 27: 22922301.
  • 30
    Galkina, E. and Ley, K., Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 2009. 27: 165197.
  • 31
    Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J. et al., Role of the T-cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007. 204: 24492460.
  • 32
    Tangirala, R. K., Rubin, E. M. and Palinski, W., Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid. Res. 1995. 36: 23202328.
  • 33
    Paigen, B., Morrow, A., Holmes, P. A., Mitchell, D. and Williams, R. A., Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987. 68: 231240.
  • 34
    Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. K.and Hansson, G. K., LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001. 21: 108114.
  • 35
    Ricci, R., Sumara, G., Sumara, I., Rozenberg, I., Kurrer, M., Akhmedov, A., Hersberger, M. et al., Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004. 306: 15581561.